[ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy]

Strahlenther Onkol. 2022 Nov;198(11):1045-1048. doi: 10.1007/s00066-022-01987-2. Epub 2022 Aug 1.
[Article in German]
No abstract available

Publication types

  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Head and Neck Neoplasms*
  • Humans
  • Oropharyngeal Neoplasms* / radiotherapy
  • Oropharyngeal Neoplasms* / surgery
  • Papillomaviridae
  • Papillomavirus Infections* / complications
  • Squamous Cell Carcinoma of Head and Neck